Growth Metrics

Inspire Medical Systems (INSP) Equity Ratio (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Equity Ratio for 9 consecutive years, with 0.86 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 0.91% to 0.86 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.86 through Dec 2025, up 0.91% year-over-year, with the annual reading at 0.86 for FY2025, 0.91% up from the prior year.
  • Equity Ratio hit 0.86 in Q4 2025 for Inspire Medical Systems, up from 0.83 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.89 in Q3 2022 to a low of 0.78 in Q4 2021.
  • Historically, Equity Ratio has averaged 0.84 across 5 years, with a median of 0.85 in 2023.
  • Biggest five-year swings in Equity Ratio: dropped 6.18% in 2021 and later increased 13.61% in 2023.
  • Year by year, Equity Ratio stood at 0.78 in 2021, then grew by 13.12% to 0.88 in 2022, then decreased by 3.67% to 0.85 in 2023, then increased by 0.86% to 0.85 in 2024, then grew by 0.91% to 0.86 in 2025.
  • Business Quant data shows Equity Ratio for INSP at 0.86 in Q4 2025, 0.83 in Q3 2025, and 0.84 in Q2 2025.